PAG
EXAS

Pinnacle Advisory Group’s Exact Sciences EXAS Stock Holding History

Pinnacle Advisory Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$334K Buy
+2,532
New +$347K 0.02% 194

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Pinnacle Advisory Group's EXAS Position: Q1 2021 in Review

Pinnacle Advisory Group opened a new position in Exact Sciences (EXAS) in Q1 2021: 2,532 shares worth $334K. The stake represents 0.02% of the portfolio and ranks #194 among its holdings.

646 funds tracked by Wall St. Rank hold EXAS as of Q1 2021.

  • Pinnacle Advisory Group held 2,532 shares of Exact Sciences worth $334K as of Q1 2021.
  • Exact Sciences was a new Pinnacle Advisory Group position in Q1 2021.
  • Exact Sciences made up 0.02% of Pinnacle Advisory Group's portfolio in Q1 2021, its #194 holding.
  • 646 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2021.

Based on Pinnacle Advisory Group's 13F filing for Q1 2021, filed 12 May 2021.